After review by the Data and Safety Monitoring Board, the dosing of OCU200 in patients with diabetic macular edema (DME) will ...
Clinical Trials Arena on MSN13h
Icon integrates Medidata’s Clinical Data Studio into clinical studiesClinical research organisation (CRO) Icon has begun the integration of Medidata Clinical Data Studio into its clinical ...
Harsha Vardhan Reddy Yeddula's research highlights the transformative power of AI in reshaping clinical trials, paving the ...
KOS AI to Host Press Conference on Argus: A Non-Invasive Blood Glucose Monitoring Breakthrough ...
Pharmaceutical Technology on MSN10d
Amid deglobalising trade, experts seek AI safeguards for clinical trial supplyThe role of AI in supply chain management proved to be the focal issue at the recent 2025 Clinical Trial Supply Europe ...
The Clinical Trials Research Pillar in the Division of Biostatistics is at the forefront of innovative clinical trial design ...
The Data Safety Monitoring Board (DSMB) identified no safety concerns, and recommended continuation of BriaCell’s pivotal Phase 3 study of ...
The Phase 2a clinical trial is designed to evaluate the safety ... to the signs and symptoms of their ESLD. A data safety monitoring board monitors each cohort of patients (N=4) to evaluate ...
A study indicates ALS Functional Rating Scale-Revised self-assessments using a smartphone app were as reliable as those done ...
The first patients have been enrolled in the HEROES trial, exploring de-escalation of anti-HER2 therapy in metastatic HER2+ ...
The potential applications of artificial intelligence (AI) in biopharmaceuticals appear wide-ranging and transformative.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback